Electromed

Electromed is a mission-driven, publicly traded medical device company with a 30-year history of dedicated innovation in airway clearance therapy. The company has achieved niche market leadership with its SmartVest system, demonstrating a proven strategy of U.S.-based manufacturing, direct-to-patient support via respiratory therapists, and continuous product refinement. Its core focus is on expanding access to its clinically validated HFCWO therapy to improve patient outcomes and reduce healthcare costs associated with chronic respiratory diseases.

Proprietary High Frequency Chest Wall Oscillation (HFCWO) technology, delivered via an inflatable vest and air pulse generator, to mechanically loosen and clear mucus from the airways.

Electromed's primary direct competitor is Baxter's Vest system. It also competes with alternative airway clearance modalities like PEP devices. Its competitive advantages are its singular focus, strong clinical evidence in bronchiectasis, U.S. manufacturing, and direct respiratory therapist support model.